Olon Spa

Activities: Ingredients

Olon Group is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical synthesis and biological processes while always embracing the highest international safety, quality, and environmental standards.

Trending Articles

  1. Limula bags US patent for cell & gene therapy manufacturing technology The automated technology is designed to streamline the cell and gene therapy production process, paving the way for point-of-care manufacturing within hospital facilities
  2. Roquette debuts Health & Pharma Solutions, Nutrition & Bioindustry subsidiaries The company has created two new organisations; Roquette Health & Pharma and Roquette Nutrition & Bioindustry, following its acquisition of IFF Pharma Solutions
  3. ProBioGen to provide cell line development services to Polpharma Biologics The biotech will help produce a high-quality, high-yield biosimilar using CHO.RiGHT, its cell line development platform
  4. DFE Pharma achieves ISO 22301 certification for BCMS DFE Pharma's Business Continuity Management System (BCMS) at its head office in Goch, Germany helps it to effectively maintain its operations
  5. RCPE and InSilicoTrials to digitalise and accelerate the development of pharmaceutical manufacturing processes RCPE and InSilicoTrials have agreed to an exclusive partnership to commercialise the XPS simulation software. Specifically developed for pharmaceutical applications, XPS allows...

Upcoming event

Boosting Sustainability and Efficiency in Pharma Manufacturing

14 May 2025 | Virtual See all

Related Content

Sustainability

Olon releases its annual ESG report

The Italian Group, leading international API supplier, presents the 2023 sustainability report and confirms the sustainability journey toward energy transition, investments in alternative energy sources, social and economic involvement and support for the communities in which it operates
Manufacturing

Manufacturing Chemist Stand Side with Olon Spa

We discover what exhibitors at CPHI Milan 2024 are showcasing LIVE!
Manufacturing

Olon commits to ultra-potent compound manufacturing expansion with new €25m facility

The CDMO's integrated small and large-scale lines can produce payloads, linker payloads and ultra-potent APIs for customers across Europe
Manufacturing

Olon strengthens market position with acquisitions ahead of CPHI Milan

Two new acquisitions expand Olon’s service offerings and production capacity
Manufacturing

Olon publishes white paper on managing nitrosamine standards

Company's rapid response to FDA, EMA, and Health Canada regulations highlighted in new publication
Ingredients

Olon continues its growth with a new acquisition

The acquisition of Huvepharma Italia Srl increases production capacity and expands market presence
Manufacturing

Olon Group acquires GTP Bioways to expand biotech offering

Olon's acquisition of the French group will boost its biotechnological capabilities, supporting customers end-to-end with the development and manufacturing of biotherapeutics
Subscribe now